Abstract
Honey and other bee products have been subjected to laboratory and clinical investigations over the past few decades, the most significant discovery being their antibacterial activity. The emer- gence of antibiotic-resistant strains of bacteria has made the current use of antibiotic therapy problem- atic, resulting in earlier remedies being reassessed. Honey, propolis, royal jelly and bee venom, all ex- hibit strong antibacterial activity. Even antibiotic-resistant strains such as methicillin-resistant Staphy- lococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) have been found to be as sensitive to honey as the antibiotic sensitive strains of the same species. The main problems in using bee products for medical purposes involve dosage and safety. The increased availability of licensed medical products containing bee products means that clinical use will probably grow and further evidence will become available. Use of such products in professional treatment centers should be limited to those which are safe and that exhibit proven antibacterial activities.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call